Your browser doesn't support javascript.
loading
Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
Wang, Yan; Liang, Wei-Cheng; Pan, Wen-Liang; Law, Wai-Kit; Hu, Jian-Shu; Ip, Denis Tsz-Ming; Waye, Mary Miu-Yee; Ng, Tzi-Bun; Wan, David Chi-Cheong.
Afiliación
  • Wang Y; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Liang WC; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Pan WL; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Law WK; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Hu JS; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Ip DT; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Waye MM; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Ng TB; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region.
  • Wan DC; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: chicheongwan@cuhk.edu.hk.
Phytomedicine ; 21(11): 1310-7, 2014 Sep 25.
Article en En | MEDLINE | ID: mdl-25172795

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Silimarina / Movimiento Celular / Receptores CXCR4 / Quimiocina CXCL12 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2014 Tipo del documento: Article Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Silimarina / Movimiento Celular / Receptores CXCR4 / Quimiocina CXCL12 Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2014 Tipo del documento: Article Pais de publicación: Alemania